Webinar | October 31, 2022

Gene Therapy Roundup: What To Know Now From The Lab To The FDA

Gene therapy continues to evolve rapidly - from the science to the regulatory requirements. To give you a greater perspective on recent developments, this panel discussion brings together gene therapy experts across assay development, regulatory submissions, and clinical trial strategy who will share observations from the front lines on a multitude of gene therapy and rare disease projects.

This event will be of interest to anyone involved in gene therapy clinical trial conduct, translational research, regulatory affairs – and anyone seeking to ensure successful gene therapy clinical development in the current climate.

Attendees will hear about:

  • Advances in gene therapy assay development
  • Validating gene therapy companion diagnostics--considerations for ensuring CDx approval
  • Optimizing the likelihood of preclinical and clinical trial development success
  • Winning strategies for rare disease trial design and regulatory submissions in the US and EU

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene